MEDICINAL COMPOSITIONS FOR PREVENTING OR TREATING DIARRHEA
    7.
    发明公开
    MEDICINAL COMPOSITIONS FOR PREVENTING OR TREATING DIARRHEA 审中-公开
    医疗中心ZUSAMMENSETZUNGEN ZUR PREVENTION ODER BEHANDLUNG DERDIARRHÖ

    公开(公告)号:EP1197214A1

    公开(公告)日:2002-04-17

    申请号:EP00942374.0

    申请日:2000-06-28

    IPC分类号: A61K31/7012 A61P1/12

    摘要: Provided is a pharmaceutical composition for the prevention or treatment of a diarrhea, which comprises as an active ingredient, siastatin B or a siastatin B derivative having a β-glucuronidase inhibitory activity. Siastatin B or the siastatin B derivative is useful as a drug for the prevention or treatment of a diarrhea, which is capable of ameliorating the diarrhea disorders as induced as a side effect when a cancer-bearing patient received the administration of an anticancer chemotherapeutic agent, particularly an anticancer camptothecin derivative acting as a topoisomerase I inhibitor. This composition is effective to prevent or treat such diarrhea as induced by the administration of an anticancer camptothecin derivative to the cancer-bearing patient.

    摘要翻译: 提供了用于预防或治疗腹泻的药物组合物,其包含作为活性成分的具有β-葡糖醛酸糖苷酶抑制活性的西司特汀B或西司他丁B衍生物。 西塔他汀B或西沙星汀B衍生物可用作预防或治疗腹泻的药物,当患有癌症的患者接受抗癌化学治疗剂的施用时,其能够改善作为副作用诱导的腹泻病症, 特别是作为拓扑异构酶I抑制剂的抗癌喜树碱衍生物。 该组合物有效地预防或治疗由向抗癌患者施用抗癌喜树碱衍生物诱导的这种腹泻。